Beijing Yizhuang Innovative Ecological Conservation Biomedicine Industry Upgrade Edition

The new generation of antibiotic information mesterin research institute and inxanduin drug patent pool was recently established in Beijing Economic and Technological Development Zone, the development zone to build a full range of "six-in-one" scientific and technological innovation
service system in the of biomedicine industry an important practice to create a "main position" for the construction of science and technology innovation center in Beijing, the development zone is making every effort to build a industry alliance, industrial research institutes, patent pools, technology trading platforms, funds and characteristic industrial park six-in-one all-round scientific and technological innovation service system At present, the development zone has established a scientific and technological innovation system for biomedicine innovation, covering professional and technical services, public basic services, policy support services, conditional support services and results-based transformation services, with the goal of enhancing independent innovation and sustainable development of industry, gathering innovative resources at home and abroad as the carrier, and modularizing and standardizing new drug research and development after a long period of cultivation and accumulation, the development zone gathered a number of well-known domestic and foreign biopharmaceutical enterprises, especially in the high-end pharmaceutical preparations, antibody drugs, vaccines and other sub-sectors leading the national high-end, leading talent gathering, innovative research and development system, the biopharmaceutical industry began to take shape, with excellent efficiency, high taxes, low energy consumption, small footprint, environmental friendliness, stable development and other characteristics, in line with the capital"high-precision" industry positioning in 2014, the biopharmaceutical industry (including commercial) in the development zone achieved operating income of 55 billion yuan, up 9.3% YoY Total profits amounted to 4.75 billion yuan, accounting for 28.5% of the profits of all industrial enterprises in the development zone With a profit margin of 12.5%, it is the leading of the six major industries in the development zone As the lowest energy consumption industry in the region, the combined energy consumption in 2014 was 345,000 tons of standard coal, accounting for 5.1% of the total energy consumption of industrial industries above the size of the region At present, the development zone has gathered 572 biopharmaceutical-related enterprises, including a large number of strong technical strength and top professionals of biomedical research and development, production enterprises These include a number of well-known biopharmaceutical multinational enterprises, such as Bayer, Sanofi, First Three and other world's top 100 pharmaceutical companies; In the joint venture, Ted introduced lipid microsphere target technology from Japan, Batey and Cuba to carry out antibody drug technical cooperation, in recent years, the rapid growth, broad prospects At the same time, Kanglong Huacheng, Yiqiu Shenzhou, Baio setchart and a number of overseas returning enterprises with professional and technical advantages stand out in the field of research and development services the future, the development zone will further establish and improve the biopharmaceutical science and technology innovation service system, accelerate the pace of innovation-driven industrial transformation and upgrading The development zone will focus on improving the level of industrial innovation and output, guiding scientific research activities to the development of heavy patents, heavy standards and heavy industrialization, accelerating the transformation of scientific and technological achievements into real productivity, realizing the close integration of innovation and industrial development, significantly improving the contribution rate of innovation in industrial development, and making every effort to build a healthy industrial environment At the same time, the development zone will also promote the institutional innovation of the transformation of scientific and technological achievements, accelerate the construction of a new mechanism of risk sharing and benefit sharing of enterprises to transform scientific and technological achievements; In addition, the development zone will strengthen the accumulation of space in the southern industrial clusters, forming an industrial technology innovation center Expand the three major innovation clusters of biomedicine, biomedical and intelligent medical devices, foster new models and new business forms for health services such as medical e-commerce, medical (drug) networking, wearable devices and service-driven, and consolidate and enhance research and development outsourcing, technology transformation, and advantage pharmaceutical products is expected to exceed 80 billion yuan in industrial scale, gathering "six batch", that is, a group of national biopharmaceutical innovation research and development center, laboratory, engineering technology center, a group of global influence of biopharmaceutical leaders (research and development innovation, entrepreneurs), a number of global influence of the original innovation varieties, a number of best-selling varieties, a number of international and domestic well-known large-scale leading enterprises and a number of multinational pharmaceutical companies Disclaimer: This article represents the author's personal opinion only and is not related to The Globe Its originality and the text and content of the statement sritten in this article has not been confirmed by this site, this article and all or part of the content, the authenticity, integrity, timeliness of this site does not make any guarantee or commitment, please readers only for reference, and please verify the relevant content.